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Abstract 
Recently, there has been a larger use of 2-NBDG, a fluorescent glucose analog, to 
study glucose uptake in different cell types. These cell types have ranged anywhere 
from bacteria to human cancer cells. However, there has yet to be a standard procedure 
and practice for using 2-NBDG. In this study, our goal is to create a standard fasting 
time for the cells before introducing 2-NBDG to them. This study uses 4T07 cells, a 
murine breast cancer cell line, to help optimize this fasting time. These cells were fasted 
at different time points in order to find the ideal fasting time. This ideal fasting time 
ensures the highest uptake of 2-NBDG in the cells. Intensity measurements, resulting 
from 2-NBDG fluorescence, were calculated to determine the optimal fasting time. The 
following paper details the procedure used including cell culturing and passaging, 
microscope setup, fluorescent imaging, and image processing.  
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1. Introduction: 
Through the years, research has shown that cancer cells exhibit increased 
amounts of glucose uptake when compared to normal cells [1]. Initially it was believed 
that cancers will always show an increase in aerobic glycolysis, which came to be 
known as the Warburg Effect [2]. However, recently the validity of the finding has been 
up for debate by researchers. Zu et al. concluded in their research that cancer cells 
might be glycolytic in vivo due to a hypoxic environment [3]. To this date, more research 
needs to be done to learn why cancers lean towards glycolysis or OXPHOS. Conclusive 
research is needed on all cancer cell lines to have concrete data on the metabolic 
properties of the different cancers.  
To study increased glucose consumption in cancers, many researchers have 
used the positron emission tomography (PET) technique with the glucose analog tracer 
fluorodeoxy-glucose (FDG) [2]. However, Bingsheng Huang et al. studied the effects of 
using PET/CT scanners and concluded the scans are accompanied by increased 
radiation dosage and cancer risk [4]. Other difficulties with radiotracers, like FDG, 
include disposing of radioactive waste [5]. Researchers must evaluate the negative 
effects of using FDG-PET compared to the gain in the research results. More recently, 
an analog of FDG has been used in researching glucose uptake in cancer cell lines. 2 
[N-(7-nitrobenz-2oxa- 1, 2-diaxol-r-7l) amino]-2-deoxyglucose (2-NBDG) has been a 
novel tool for imaging glucose uptake without having the side effects of radiation 
exposure. 2-NBDG has been studied in a variety of cell lines which shows the versatility 
of the glucose analog. Yoshioka et al. studied the application of 2-NBDG in E. coli [6]. 
O’Neil et al. researched the uptake of 2-NBDG in nonmalignant epithelial cells, breast 
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cancer cells, and liver cancer cells [7]. Zou et al. used 2-NBG as a fluorescent indicator 
to measure glucose uptake in human hepatocarcinoma cells and in rat skeletal muscle 
cells [5]. Langsner et al. studied 2-NBDG uptake in excised breast cancer tumors and 
normal breast tissue. From this research, it has been concluded that 2-NBDG uptake in 
cancerous breast tissue is inherently higher than non-cancerous breast tissue based on 
fluorescence signal intensity values [8].  
There are many parameters involved in using 2-NBDG to measure glucose 
uptake in different cell lines. Such parameters include fasting time of the cells, 
concentration of 2-NBDG, and incubation time with 2-NBDG. Zou et al. studied different 
concentrations of 2-NBDG as well as different incubation times with 2-NBDG present 
[5]. In order to effectively uptake 2-NBDG, cells must be fasted in media that does not 
contain d-Glucose. It has been shown by O’Neil et al. that media containing d-Glucose 
inhibits the uptake of 2-NBDG by competing for the glucose transporter (GLUT) to enter 
the cell [7]. When 2-NBDG is taken up into cells it becomes phosphorylated by 
hexokinase at the C-6 position which results in the fluorescent marker being trapped 
inside the cell [7]. Yoshioka et al. determined that the 2-NBDG metabolite was in fact 2-
NBDG 6-phosphate by comparing molecular weights of the two [9]. By confirming the 
metabolite of 2-NBDG, it has been determined that 2-NBDG is an effective fluorescent 
marker for studying glucose uptake.  Further research has shown that adding 10% fetal 
bovine serum (FBS) increases cell viability while fasting the cells in glucose free media 
[10]. With the addition of FBS to media lacking glucose allows researchers to keep cells 
viable with long fasting times, such as up to 150 minutes [10].  
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 Since different studies have performed different fasting times [1,6-9], this paper’s 
goals are to gain data from experiments on murine Balb/cfC3H cell lines to determine 
the ideal fasting time for cultured cancer cells before introducing 2NBDG to them. The 
fasting time can be defined as the amount of time cells are incubated without proper 
nutrients (glucose). To determine the ideal fasting time, multiple images were taken for 
each time point to observe the different intensities. We believed that by studying 
different fasting times we could find the most suitable amount of time for cells to be 
fasted prior to the addition of 2-NBDG to ensure the highest uptake of the fluorescent 
glucose analog. After finding this time, ex vivo tissue can be studied using the same 
fasting time found here to observe 2-NBDG uptake. It was decided to test 2-NBDG 
uptake at four different fasting times: 15 minutes, 30 minutes, 60 minutes, and 90 
minutes. 2-NBDG uptake was also measured without fasting the cells prior to the 
addition of 2-NBDG (0 minutes).  
 In order to find the most appropriate fasting time for breast cancer tissues, it was 
decided to use the 4T07 cell line. The 4T07 cell line is one of the four tumor sublines 
that were isolated by Dr. Fred Miller from a spontaneously arisen tumor in a Balb/c 
mouse [11]. The 4T07 cell line is commonly used by researchers as a model for human 
mammary cancer because it is highly tumorigenic and has low metastatic potential [11]. 
As seen below, in Table 1, the different cell lines from this spontaneous tumor reach 
different levels of metastasis. 4T07 cells can be found in the blood and lungs, but no 
metastases ever form. Although the cancer cells do spread out from the primary 
location, they will not form tumors elsewhere. Using data found in this paper, along with 
other research [12], we can start to understand more about the metabolic processes 
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and glycolytic demand of different breast cancer cell lines. Since it has already been 
shown that 2-NBDG uptake is higher in cancerous breast tissue compared to non-
cancerous tissue [8], we will be able to effectively differentiate between metastatic 
cancers from non-metastatic cancers. This will give physicians an advantage in 
diagnosing cancers. By knowing the specific metabolic properties and metastatic 
potential of cancer cell lines, physicians will be able to effectively treat patients with 
properly diagnosed cancer. 
 
Table 1: Seen below is a table representing the metastatic capability of the sublines 
derived from a Balb/c mouse.  
 
 
2.Methods: 
2.1 Cell Culturing 
As stated previously, this study focuses on studying the 4T07 cell line that was 
derived from a spontaneous breast tumor in a Balb/c mouse [10]. The cells were 
obtained from storage, thawed, and placed in a 75cm2 flask with media.  The media 
 Invasion Metastasis Location 
67NR Primary Tumor only   N/A 
168FARN Local Invasion, Intravasation  Lymph Nodes (no 
nodules) 
4T07 Extravasation  Blood, Lungs (no 
nodules) 
4T1 Metastatic Growth  Lung, Liver, Bone 
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used was Dulbecco’s Modified Eagle’s Medium (DMEM) (+) glucose with the addition of 
10% (v/v) FBS, 2mM L-glutamine, 1% (v/v) nonessential amino acids, and 1% (v/v) 
penicillin-streptomycin. The cell culture flask was placed in a humidified incubator that 
was set to 5% CO2 and 37 °C. Once the cells had reached approximately 80% 
confluency they were passaged into a new flask with DMEM. Cells were passaged 
based on standard cell culture techniques. After three passages, the cells were deemed 
ready to be used for the experiments.  
2.2 Cell Plating 
Once the cells were deemed ready to be passaged based on confluency, cells 
were plated at the same time. Three sample plates and one control plate was used for 
each fasting time point. For an adequate signal, it was decided to suspend 300,000 
cells with 2 mL of DMEM in 35mm MatTek glass bottom dishes. Glass bottom dishes 
were used to warrant a true fluorescent signal from the cells without any interference 
from plastic. The total volume of cells used was dependent on the number of living cells 
per milliliter. Cell viability was measured using the Countess II Automated Cell Counter. 
The plated dishes were placed in the humidified incubator at 5% CO2 and 37 °C for 24 
hours. 4T07 cells were plated in four plates for each of the four fasting times plus the 
baseline. This gives a total of 20 plates for the 4T07 cell line.  
2.3 Fasting and Fluorescence Imaging  
Once the 24-hour incubation time was completed, plates were taken out of the 
incubator individually to undergo fasting. The DMEM media was removed from the 
plates and each was washed with PBS to ensure there was no glucose left in the plate. 
After washing, 0.5mL of DMEM (-) glucose was added to each plate. With the addition 
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of the glucose free media, plates were put into the incubator to “fast” per their respective 
times (0, 15, 30, 60, 90 minutes). After the respective fasting times were completed, 
plates were removed from the incubator to allow the addition of 2-NBDG. Each plate 
received 2-NBDG at a concentration of 400μM and was incubated for 20 minutes. This 
concentration was chosen based on prior studies [9]. After the 20-minute incubation 
time was completed, plates were removed and washed twice with PBS to ensure proper 
removal of 2-NBDG. 1mL of DMEM (-) glucose was added to each plate prior to 
imaging.  
 Fluorescent imaging was done using an Olympus IX81 microscope, shown in 
Figure 1. The optical setup includes an Olympus IX2-UCB controller, 75-Watt Xenon 
Burner, and a Hamamatsu Digital Camera. Images were taken using a 10X objective 
with a 2x2 binning. Based on the excitation/emission profile of 2-NBDG, an excitation 
filter of 465nm was used. The microscope was initially set up to view the cells using 
bright field microscopy. Once cells were in focus, the shutter was opened to allow the 
fluorescent excitation light reach the sample. From here, an image was captured, and 
then the stage was moved until the next FOV was chosen. A total of 5 images were 
taken per plate.  
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Figure 1: Above is the microscope setup used for imaging 4T07 cells.  
 
2.4 Image Analysis 
 Using MATLAB, fluorescence intensity values were analyzed and calculated. 
Each image was run through a program to select a background region of interest. The 
average intensity of the ROI was measured and subtracted from each individual image. 
The average intensity of each image was calculated after background subtraction. This 
final intensity value is used for results.  
2.5 Statistical Analysis 
A nested, one-way analysis of variance test (ANOVA) was performed for intensity 
values of 2-NBDG 4T07 cells. The breast cancer cell lines used and the fasting times 
were considered fixed effects. The different plates and fields of view for each plate were 
nested in each group and considered to be random effects.  
Olympus 
IX2-UCB 
Controller 
75 Watt 
Xenon Burner 
Hamamatsu 
Digital 
Camera 
Olympus IX81 
Microscope 
10X Objective 
465nm 
Excitation 
Filter 
Hand switch  
 
 
10 
 
 
    
     
 
 
 
 
 
 
 
 
Figure 2: Shown above is brief flow chart that overviews the methods performed.  
represents the procedure for the 4T07 cell line. One additional plate was used for each 
fasting time, but did not receive any 2-NBDG.  
 
3. Results: 
4T07 Studies: 
Images taken from each fasting time are shown in Figure 3 for 4T07 cells. After 
a nested, one-way analysis of variance test, there was shown to be no significant 
difference in 2-NBDG uptake intensity values for 4T07 cells. 
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Figure 3: A. 2-NBDG uptake in 4T07 cells with a 0-minute fasting time. B. 2-NBDG 
uptake with a 15-minute fasting time. C. 2-NBDG uptake with a 30-minute fasting time. 
D. 2-NBDG uptake with a 60-minute fasting time. E. 2-NBDG uptake with a 90-minute 
fasting time. F. Control image of 4T07 cells without the addition of 2-NBDG. As seen in 
all 5 images, there is little variation in intensity between the different fasting times. 
Images shown above were processed using MATLAB and background-subtracted. The 
calculated background intensity is then subtracted from the total image to give the final 
images seen above. Images A-F were used to calculate the average intensity of each 
time point. The color bar represents intensity values as it relates to 2-NBDG uptake. 
Each image is 1024x1024 pixels and 1.3x1.3 mm.  
A B C 
F E D 
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Figure 4: Represented above is the average intensity measured from 2-NBDG uptake 
at each time point. Baseline corresponds to no fasting time. Intensities from each plate 
were averaged from 5 different fields of view. No significant difference was found 
between time points from the nested, one-way ANOVA. Error bars show standard 
deviation. Due to the discrepancies in the fasting time’s control values, we cannot 
successfully determine if one fasting time is preferred over others.  
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Conclusion:  
 After obtaining high quality images of 4T07 cells post 2-NBDG introduction, we 
have shown the potential and need of a standard practice for 2-NBDG uptake. While 
going through the imaging process, we figured the best optical setup for our microscope 
and camera. Originally, we used an LCTF to control the input of light into the camera. 
However, the resultant images were not as clear as needed. It was decided to take off 
the LCTF to allow all wavelengths of light reach the camera. This allowed us to get the 
best quality of image possible without overexposing the CCD. It also reduced the 
complexity of the imaging process by not having to make the decision of what 
wavelengths would be passed through the LCTF.  
 Looking at the data from the 4T07 studies we can see discrepancies in intensity 
values. These discrepancies will not allow us to reach a reasonable conclusion on 
which fasting time should be preferred. The issue arises not in the data from the 
samples but from the control plates. We have seen too high of deviations (Figure 4) in 
intensity values from each time point’s control plate. This makes the data flawed. The 
control plates must all have similar intensity values for accurate analysis of the sample 
data. Since the control plates have such different intensity values, this might mean the 
output of the fluorescent burner was not constant on a day to day basis. Potentially, the 
burner had a different output hourly as well. Even with looking at the sample values, the 
nested, one way ANOVA test concluded there was no significant difference in fasting 
times. However, we can still take away the optimal protocol for introducing 2-NBDG and 
imaging the cells. Based on other work in our lab, we have previously determined that 
FBS is necessary when fasting cells and that 400μm is an adequate concentration of 2-
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NBDG [9]. Along with this previous information and the information gained from these 
studies, we have shown the great possibilities of 2-NBDG being a novel tool for studying 
glucose consumption in cancer cells.  
 
 
Future Directions 
More work needs to be done in order to establish a uniform protocol for 2-NBDG 
studies. The experiments conducted here provide good preliminary data for optimizing a 
protocol. In order to ensure there is no discrepancies in the data, all samples should be 
tested in one day, after the microscope, camera, and burner are all calibrated. Tests 
should be run to ensure a uniform output of power from the burner before and after 
imaging is conducted. This will ensure the controls for each time point must have similar 
intensity values with low standard deviation. This allows the researcher to properly 
observe and analyze the differences in intensities seen in different fasting times. In the 
future, more experiments should be performed on the different breast cancer cell lines 
as well as expanding to different cancer types. Once the 4T1 family of cell lines has 
been thoroughly studied with 2-NBDG, the information learned can be tied with redox 
ration and oxygen consumption. This will help further the knowledge on metabolic 
properties of the breast cancer cell lines. By finding the optimal fasting time for other 
cancer types, we can begin to compare the similarities and differences in cancerous 
cells’ other metabolic tendencies. Finding this optimal fasting time will let future 
researchers have a standard fasting time for in vivo studies. From there, researchers 
can effectively compare glucose uptake in tumors in vivo. This allows researchers to 
understand the kinetics behind glucose uptake in vivo. Along with glucose uptake, the 
 
 
15 
 
breast cancer cell line family can be further studied to learn about redox ratio and 
oxygen consumption. Using redox ration, oxygen consumption, and glucose uptake, 
researchers will have a detailed knowledge on the metabolic properties of the cancer 
cell lines. This will allow physicians to properly diagnose and treat patients with select 
cancers.  
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